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Abstract
Background and aims: Hypertension is one of the most important risk factors for 
coronary heart disease. Recent studies have pointed out the possibility that virgin 
olive oil may lower blood pressure in hypertensive subjects. However, until the date 
there is scarce information regarding elderly people. The present study was designed to 
assess the effect of dietary virgin olive oil on blood pressure in medically-treated 
hypertensive elderly patients. 
Methods: 31 medically-treated hypertensive (HT) elderly patients and 31 
normotensive (NT) elderly volunteers participated in a randomized sequential dietary 
intervention. Subjects consumed diets enriched in sunflower oil (SO) or virgin olive oil 
(VOO) for four weeks each with a four-week washout period between them. 
Results: VOO reduced total and LDL-cholesterol in NT but not in HT (p<0.01) and the 
concentrations were lower than in the group consuming SO. In contrast, no significant 
differences were found in the levels of tocopherols among the groups studied. Iron-
induced oxidation of LDL resulted in a complete loss of monoacylglycerols (MG) and 
diacylglycerols (DG) and a reduction in triacylglycerols (TG) (60-80%), which was 
found to be greater in HT (p<0.01) with no effect of diet. VOO consumption 
normalized systolic pressure in the HT group (136 ± 10 mmHg) compared to SO (150 
± 8 mmHg). Conclusion: dietary VOO proved to be helpful in reducing the systolic 
pressure of treated HT elderly subjects. However, a greater resistance to the lowering 
effect of VOO of total and LDL-cholesterol and a greater susceptibility to TG oxidation 
was detected in these patients.  
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Introduction
In elderly people, both isolated systolic hypertension and combined 
systolic/diastolic hypertension are considered the most important risk factors for 
coronary heart disease morbidity and mortality (1). In fact, hypertension affects more 
than one half of the elderly and its prevalence increases with age (2). When 
hypertension is treated, the cardiovascular morbidity and mortality is reduced to a 
greater extent than could be expected from the results of trials in middle-aged 
subjects (3). However, nutritional supplementation has acquired an important 
relevance, partially because many antihypertensive agents elevate low-density-
lipoprotein-cholesterol (LDL) or triacylglycerol (TG) concentrations and/or lower high-
density-lipoprotein-cholesterol (HDL) concentrations, paradoxically increasing the 
cardiovascular risk (4,5). 
Despite fish oil or n-3 fatty acid supplementations have been employed as 
adjuvants in the treatment of hypertension, several studies did not find a reduction in 
blood pressure of hypertensive (HT) patients, when compared with virgin olive oil 
(VOO) supplementation (6,7). We demonstrated that the intake of VOO lowers both 
systolic and diastolic pressures in normocholesterolemic and hypercholesterolemic 
hypertensive women when compared with a diet enriched in high-oleic sunflower oil 
(HOSO) (8). In addition, VOO, but not HOSO, also normalized some of the impaired 
functions of the erythrocyte membrane in HT (9). Subsequently, other authors have 
corroborated our findings (10,11). 
The concentration of antioxidants in VOO has also been related to a resistance 
of LDL to oxidation (12,13).  Oxidative modification of LDL has been implicated as an 
important determinant in the development of atherosclerosis (14). Susceptibility of 
plasma LDL to oxidation from different subjects ex vivo is highly variable and is 
related, among other factors, to the TG, polyunsaturated fatty acids (PUFA) and 
vitamin E contents (15). In fact, LDL oxidation is increased by adding PUFA to the 
diet, such as SO, and decreased by adding vitamin E. De Waart et al., (16) reported 
that supplementation with vitamin E in the elderly is beneficial for lowering the rate 
of oxidation of linoleic acid in the LDL of elderly people, whose LDL are more 
susceptible to oxidation (17). LDL are also more prone to be oxidized in patients 
affected by hypertension (18) but it that can be prevented adding vitamin E to the 
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diet since it reduces the susceptibility to oxidative modification of LDL by means of 
increasing oxidation lag time (19). 
The present work was conducted with the aim of evaluating the effects of 
dietary VOO and SO on blood pressure and on the lipid composition of LDL and 
oxidized LDL (oxLDL) in a group of non-diabetic medically-treated HT elderly people 
(average age 84y). In addition, we evaluated the concentration of α-tocopherol and 
other vitamins and non-fatty acid constituents of dietary VOO that might be related 
to the susceptibility of LDL to oxidation. 
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Subjects and Methods
The study was performed at Residencia Heliópolis (Junta de Andalucía, Seville, 
Spain), a residential home for the elderly, where the diet of all participants was 
controlled. 42 women and 20 men (31 NT and 31 HT), who were residents at the 
beginning of the study, gave written, informed consent to a protocol approved by the 
Institutional Committee on Investigation in Humans (Hospitales Universitarios Virgen 
del Rocío, Seville, Spain). All participants had been residents of the Residencia 
Heliópolis for at least 5 years, consequently all their habits were completely known. 
HT volunteers had been suffering from hypertension for at least the last 5 years and 
were medically-treated with beta-blockers and diuretics. None of them was diabetic 
or suffered from glucose intolerance or hypothyroidism. Fasting glucose levels were 
101.1 ± 28.1 mg/dL for normotensives and for hypertensives 95.1 ± 12.6 mg/dL. 
Cigarette smokers were excluded from the study and no case of alcohol abuse was 
detected among participants. 
Diets
The participants were successively fed two diets enriched in SO or VOO for four 
weeks each. A 4-week washout period was included between experimental periods, 
consisting on the habitual dietary fat, comprised of refined oil and a blend of seed 
oils. Before the study, the health officers recorded the habitual dietary intake of the 
participants during four consecutive weeks, using a 24h recall and food frequency 
questionnaires. The energy consumption and nutrient intake were calculated, 
approved by a dietician and employed as a basis for the diets of the study. The 
studied diets were based on ordinary food and were planned for every four-week 
period and were revised every week. The diet was adjusted to 30% of the energy as 
fat, 55% as carbohydrates and 15% as proteins. Oils were added to the diet in a daily 
dose of 60g. The fatty acid composition of the oils was performed by gas 
chromatography as described below and is shown in Table 1.  Three diet samples 
were collected in each experimental period to be analyzed for their fat content and 
other nutrients. One investigator was present several times in the kitchen during 
meal preparation without previous notification. The energy consumption was 
approximately 1800 kcal/day. Sodium intake was identical in both experimental 
periods.
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Blood Pressure Measurements
Blood pressure measurements were performed in the morning, after an 
overnight fast, at the right brachial artery in seated participants using a mercury-
gauge sphyngomanometer. The measurements were recorded by the same nurse at 
the residential home at the beginning, middle and end of every experimental period. 
At each visit three blood pressure measurements were recorded and the average 
used to determine eligibility.
Serum lipid and lipoprotein analyses
Venous blood was obtained in fasting status after an overnight period, at the 
beginning and end of each period of the study. Blood was collected in Vacutainer 
tubes and serum obtained by centrifugation at 1500 rpm during 30 min at 4ºC . Serum 
samples  were  frozen  below  –80  ºC  until  analyzed.  Serum  total  and  high-density-
lipoprotein  (HDL)  cholesterol  and  TG  concentrations  were  measured  by  conventional 
enzymatic  methods.  Low-density-lipoprotein  (LDL)  cholesterol  concentration  was 
calculated according to the Friedewald equation.
Isolation and Oxidation of Low-Density Lipoproteins (LDL)
LDL were isolated by density gradient ultracentrifugation from 4 mL of serum 
(40000 rpm, 18 h, 15 ºC). Ultracentrifugation was performed using a SW 41 Ti rotor in 
a BECKMAN L8-70M preparative ultracentrifuge (Beckman Instruments, Inc, Palo Alto, 
USA). Lipid peroxidation was assayed by incubating LDL (1 mg of protein) in 0.05 M 
phosphate buffer, pH 7.4 at 37 °C, final volume 2 mL. The reaction was started by 
addition of ascorbate (final concentration 0.4 mM). Phosphate buffer was 
contaminated with sufficient iron to provide the necessary ferrous or ferric iron for 
lipid peroxidation.
 
Determination of Serum Vitamins and Squalene 
Squalene was determined by gas chromatography after extraction from total 
lipids using the method described by Lanzon et al. (20). Liposoluble vitamins were 
extracted from 500 µL of serum as follows. 500 µL of ethanol and 1 mL of hexane 
were added sequentially. The mixture was centrifuged (3500 rpm, 15ºC for 10 min) 
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and the supernatant collected. The hexane was evaporated under a stream of 
nitrogen and the vitamins redissolved in choloroform/methanol (2:1, v/v) for injection 
into the HPLC system. This system consisted on a reversed-phase column (Novapack, 
4x250 mm, 4 µm) and an elution system composed of methanol/acetonitrile 
(chloroform (9:78:13, v/v/v) that run isocratically. A photodiode array detector (PAD 
996, Waters) was used for α-tocopherol, γ-tocopherol and retinol detection at 290 nm 
(α-tocopherol and γ-tocopherol) and 325 nm (retinol), respectively. These compounds 
were identified by using commercial standards and quantified by means of external 
standard.  
Determination of LDL and oxLDL Lipid Classes
Total lipids were extracted following a modification of the method of Rose and 
Oaklander (21), using 2,6-di-tert-butyl-p-cresol (BHT) as antioxidant. 10 μL of lipids 
from LDL and oxLDL were dissolved in chloroform/methanol (2:1, v/v) and were injected in 
a 2690 Alliance liquid chromatograph (Waters, Milford, USA), controlled by computer 
(Millenium 34 System, Waters, Milford, USA) and provided with a Lichrosphere column 
(250 x 4.6 mm, 5-µm particle size) (Merck, Darmstadt, Germany). The liquid 
chromatograph was coupled to a light-scattering detector (DDL31 Eurosep Ins., Cergy-
Pontoise, France). The mobile phase consisted on a ternary solvent system, starting with 
0.8% of 2-propanol in hexane raising the percentage of 2-propanol to 3.0% in 8 min and 
then to 10.0 % after 17 min. From minute 17 to minute 22, the percentages of hexane and 
2-propanol were reduced to 0%, whereas that of methanol was raised to 100%. The flow 
rate was 0.8 mL/min. Standard solutions of cholesterol oleate, triolein, 1,2-diolein, 2-
monoolein, cholesterol and dipalmitoyl phosphatidylethanolamine (Sigma, St. Louis, USA) 
were used for identification and quantification. For calibration, triplicate runs of six 
concentrations of these standards (0.25 and 2.5 mg/mL in chloroform/methanol, 2:1) were 
injected. Equations resulting from regression curves of these standards were employed for 
quantification. 
Statistical Analyses
Values are shown as mean ± standard deviation. The significance of the 
difference among groups was assessed by analysis of variance (ANOVA) with Tukey’s 
post-hoc comparison of the means. Differences were considered significant with a 
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confidence interval of 99% (p<0.01). The analyses were done with Prism v3.0 
(GraphPAD Software, San Diego, USA).
Results
During the period of the study, we detected no cardiovascular, nor other 
metabolic or endocrine disease among the individuals recruited. The average age of 
the participants was 84.0 ± 7.4 y, and presented an average BMI of 28.8 ± 5.2 kg/m 2 
and a whist to hip ratio (WHR) of 0.91 ± 0.06. No relationship was found between the 
ages, BMI and WHR of the individuals. The content of total polyphenols in VOO was 
232 ppm and that of squalene was 3709 ppm. These compounds were not detected in 
SO.
The variations recorded in the blood pressure of the elderly people are 
depicted in Figure 1. Systolic pressure was normalized in HT by dietary VOO but not 
by SO. NT individuals showed values close to 139 mmHg after the period of SO 
whereas HT showed values above to 150 mmHg. In contrast, when the subjects 
consumed the VOO diet both NT and HT presented systolic pressure values close to 
135 mmHg. No significant differences were found for diastolic pressure.
The concentrations of serum lipids and lipoproteins in the group of HT were not 
significantly modified after consuming VOO compared to SO (Table 2). In contrast, 
VOO was responsible for a decrease in total and LDL-cholesterol concentrations in NT 
(p<0.01). However, a concomitant decrease in HDL-cholesterol and an increase in TG 
were also observed (p<0.01). Hypertension did not affect cholesterol concentrations 
when patients consumed VOO but when consuming SO NT showed a lower TG 
concentration in serum than HT (p<0.01).
The concentration of γ-tocopherol and α-tocopherol in serum were not modified 
by either of the diets or affected by hypertension (Table 3). However, the 
concentration of retinol was significantly higher in the elderly after consuming VOO 
(p<0.01). Unexpectedly, we did not find higher squalene amounts in serum of the 
subjects after consuming VOO than after SO. Indeed, we found the highest 
concentration of this cholesterol precursor in HT after the administration of SO. 
Six lipid classes were identified and quantified in the LDL of the elderly 
subjects (Table 4), for instance cholesteryl esters, free cholesterol, TG, 
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diacylglycerols (DG), monoacylglycerols (MG) and phospholipids. The determination 
of these lipid classes provided more information about the lowering in cholesterol 
observed in the LDL of NT (Table 2).  Indeed, such reduction was due to a lower 
cholesteryl esters concentration and not to a decrease in the amount of free 
cholesterol. The TG concentration in LDL was lower in NT after SO (p<0.01), mirroring 
total TG concentration in serum. In contrast, after VOO, the concentration of TG and 
DG was significantly higher in NT (p<0.01). No significant differences were found in 
the MG and phospholipid concentrations in LDL.
 When LDL underwent iron-induced oxidation, a loss of MG, DG and TG was 
found (Table 5 and Figure 2). DG and MG could not be detected in oxLDL and TG 
concentration was reduced in about 50-80%. The greatest oxidation of TG occurred in 
HT (p<0.01) but diet did not affect it. The reduction in the glyceride fraction occurred 
concomitantly to an increase in the cholesterol species. The proportion of free and 
esterified cholesterol was increased in LDL after the intake of either of the dietary 
oils. Although the cholesteryl ester content found in oxLDL was not significantly 
different among the groups studied, the lowest increase was found in the group of NT 
after SO (p<0.01). Oxidation did not affect the phospholipid content of LDL.
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Discussion
Newly available data is pointing out that, in addition to plasma lipids, VOO 
intake may also reduce blood pressure in HT and healthy subjects (8,10,11). The 
present work was designed to assess the effects of VOO and SO on serum lipids, the 
lipid composition of LDL and oxLDL and blood pressure of medically-treated HT 
elderly people. 
Systolic pressure was reduced in HT participants after consuming the diet rich 
in VOO. Unfortunately, for the moment there is scarce information on the effect of 
dietary oils on blood pressure in aged people. Margolin et al., (4) performed double-
blind randomized-controlled studies to compare the effects of the administration of n-
3 (fish oil) and n-6 fatty acids to HT elderly people on blood pressure, showing a 
higher reduction of systolic and diastolic pressures in subjects receiving fish oil. 
However, some studies failed to find effects of fish oil or n-3 fatty acid 
supplementation on blood pressure in treated HT when compared to VOO as a 
placebo, suggesting that VOO is able to reduce blood pressure to a similar extent. 
Previously, Ruiz-Gutierrez et al. (8) had observed a hipotensive effect of dietary VOO 
in HT patients compared to another oleic acid-rich oil, such as high-oleic sunflower oil 
(HOSO). VOO, but not HOSO, normalized the altered distribution of cholesterol and 
Na+-Li+ countertransport in the erythrocyte membrane. Although it needs to be 
elucidated which of the minor constituents of VOO is/are responsible of these effect, 
on the basis of the accumulated data, we suggest that polyphenols may play a key 
role in this regard, since these compounds are absent in SO, either the wild type or 
high-oleic. The mechanism of reduction of blood pressure by polyphenols has been 
related to endothelium-dependent vasorelaxation via enhanced nitric oxide (10,22).
Classical studies have reported similar effects of dietary intake of VOO and SO on 
serum lipid concentrations of healthy subjects (23,24). However, there is still need of 
consensus, since recent works have shown increasing total and LDL-cholesterol 
concentrations after consuming VOO compared to dietary oils rich in n-6 fatty acids 
(25,26) and others have reported greater cholesterol reductions of VOO (27,28). These 
discrepancies may be due to differences in experimental conditions, including the 
employment of different varieties of olive oil as we have shown lately (29). In the present 
study we found a lower total and LDL-cholesterol concentrations in the serum of NT elderly 
individuals after consumption of VOO but not in HT (Table 2), suggesting that these 
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patients would be more resistant to modifications by diet on serum lipid and lipoproteins 
concentrations. We previously reported a lack of lowering effect of VOO on serum 
cholesterol in a group of HT postmenopausal women compared to HOSO (8). The content 
of squalene, the main hydrocarbon in VOO, has been considered 
hypercholesterolemic compared with SO (30). We found negligible differences in the 
serum concentrations of squalene in NT or HT elderly individuals after both diets 
studied, excluding any relationship between squalene concentrations and the 
observed variations in serum cholesterol. Very scarce studies on the influence of VOO 
on squalene content have been carried out and for the moment none in an elderly 
population. 
To our knowledge this is the first study in which a dietary intervention with 
VOO has been conducted in such an old population of HT individuals. Aging results in 
modifications of the risk factors related to cardiovascular disease (31). In the very 
elderly, both serum TG and LDL-cholesterol are diminished (32), as well as 
antioxidants, due to enhanced of oxidative stress (33). There are a growing number 
of studies indicating that antioxidants may be responsible for some of the protective 
effects of VOO (34,35). The concentrations of α and γ-tocopherol in serum of elderly 
people consuming either SO or VOO were not significantly different. In contrast, the 
concentration of retinol was higher in NT and HT subjects after consumption of VOO. 
Low concentrations of serum retinol or vitamin A, as well as tocopherols, have been 
related to the risk of coronary heart disease (36) and hypertension (37), even in 
elderly subjects (38). However, the supplementation of these vitamins in the diet 
seems to have no relevant effect on blood pressure at least in HT patients under 
medical treatment (39), unless a very high dose is administrated (40). Additionally, 
the role of the supplementation of these compounds on the risk of CHD is 
controversial since some interventional studies have reported no clear effect (41). 
Nevertheless, the antioxidant role of these vitamins on the resistance of LDL to 
oxidation and thus as determinant of atherosclerosis have been clearly stated in vitro 
(14). In order to study the susceptibility to oxidation of LDL obtained from elderly 
people after consumption of VOO or SO, we analyzed the actual loss of the lipids 
contained in those lipoproteins. Very commonly, oxidation in LDL is tested indirectly 
by measuring espectrophotometrically the conjugate diene formation or the 
production of lipid hydroperoxides, such as malonaldehide (MDA) or thiobarbituric 
acid reactive substances (TBARS) (42). The HPLC determination of lipid classes in LDL 
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allows checking the actual modifications of lipids occurring in LDL due to iron-induced 
oxidation. We observed a loss of glyceridic lipids (TG, DG and MG), resulting in a 
proportionate increase in free and esterified cholesterol. Both DG and MG completely 
disappeared from LDL in all groups studied (NT-VO, NT-SO, HT-VO and HT-SO) but the 
loss of TG was greater in HT, suggesting that hypertension diminishes the protection 
of LDL against iron-induced oxidation in elderly subjects. This is of particular interest 
since it has been reported that LDL peroxides and the susceptibility of LDL to 
oxidation are increased with aging (17). Frostegard et al. (18) have very recently 
showed that oxLDL are raised in serum of HT men as determined by antibody 
targeting of oxidation epitopes in LDL. In has been stated that an improvement of 
LDL resistance to oxidation is achieved by blood pressure reduction (43) and vitamin 
E supplementation (19). However, as no effect of the diet and no differences in the 
tocopherol concentrations were found, our results support the data raising doubts 
about the antioxidant effect of this vitamin.
The average BMI value of the elderly subjects was close to 28 kg/m2, which is 
usually taken as an indicator of overweight and might bias the results of the study. 
Obesity increases in advanced maturity, mainly due to changes in the body composition 
related to age. Such modification include the reduction in height, at a rate of 1-2 cm per 
year and even quicker after 85 years, resulting in an increase of BMI (44). Heiat et al. (45) 
reviewed data from 444 articles on the association of BMI and all causes of cardiovascular 
mortality in geriatric populations concluding that up to 27 kg/m2 BMI does nor represent a 
mortality risk in elderly people and suggested that the world health organization 
guidelines of BMI may be too restricted for this population. Others have even 
recommended that elderly people with BMI values between 25 and 30 kg/m2 and over 70 
years old should not be encouraged to lose weight, as it does not represent a risk for 
cardiovascular mortality (46). 
We conclude that dietary VOO is helpful in reducing the systolic pressure of 
treated HT elderly subjects, thus reducing the requirement of antihypertensive 
medication. However, in these patients we detected a greater resistance to the 
lowering effect of VOO in total and LDL-cholesterol and a greater susceptibility to TG 
oxidation compared to NT individuals, which was not related to tocopherol or 
squalene concentrations in serum. The differential effects of VOO and SO 
consumption on serum squalene content in elderly subjects should be further 
investigated.
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Table 1. Fatty acid composition of the sunflower (SO) and virgin olive (VOO) oils 
employed in the experimental diets. 
Fatty Acid 
(mg/100
mg)
SO VOO
16:0 6.4 ± 0.4 10.9 ± 1.82
16:1, n-7 0.1 ± 0.0 1.1 ± 0.32
18:0 1.6 ± 0.3 2.4 ± 1.3
18:1, n-9 t ND 0.3 ± 0.2
18:1, n-9 25.1 ± 1.4 74.6 ± 0.62
18:1, n-7 1.6 ± 0.3 3.5 ± 0.12
18:2, n-6 64.5 ± 1.2 4.5 ± 0.42
18:3, n-3 ND 0.6 ± 0.22
18:3, n-6 0.9 ± 0.1 1.1 ± 0.3
20:1, n-9 0.4 ± 0.1 0.2 ± 0.1
22:0 ND 0.8 ± 0.12
1  ± SD. n= 3.
2different from SO p<0.01. 
3ND: Not detected.
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Table 2. Serum lipid levels (mg/dL) of normotensive (NT) and hypertensive (HT) 
elderly subjects after consuming sunflower (SO) or virgin olive oil diets (VOO).
NT-SO HT-SO NT-VOO HT-VOO
TC 186.2 ± 38.1a 184.8 ± 40.5a 166.6 ± 37.7b 179.2 ± 44.2ab
LDL-C 113.0 ± 35.5a 112.0 ± 27.9a 99.2 ± 32.4b 105.7 ± 29.3ab
HDL-C 57.6 ± 17.8a 54.0 ± 18.7a 48.1 ± 14.9b 51.2 ± 17.2ab
TG 77.6 ± 30.0a 94.0 ± 33.3b 96.3 ± 43.1b 96.6 ± 42.6b
1  ± SD. n= 31.
2TC: total cholesterol, LDL-C: LDL-cholesterol, HDL-C: HDL-cholesterol, TG: 
triacylglycerols. 
3Mean values within a row sharing the same letter are not significantly 
different (p>0.01). 
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Table 3. Serum liposoluble vitamins and squalene composition (µg/mL) of normotensive 
(NT) and hypertensive (HT) elderly subjects after consuming sunflower (SO) or virgin 
olive oil diets (VOO).
NT-SO HT-SO NT-VOO HT-VOO
γ-tocopherol 0.4 ± 0.1a 0.4 ± 0.1a 0.4 ± 0.1a 0.4 ± 0.1a
α-
tocopherol
5.3 ± 1.1a
5.8 ± 1.5a 5.5 ± 0.7a 5.2 ± 0.9a
retinol 1.8 ± 0.3a 2.1 ± 0.5a 2.6 ± 0.4b 2.6 ± 0.5b
squalene 0.28 ± 0.09a 0.36 ± 0.12b 0.33 ± 0.15ab 0.26 ± 0.09a
1  ± SD. n= 31.
2Mean values within a row sharing the same letter are not significantly 
different (p>0.01). 
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Table 4. Lipid classes composition of LDL (mg/100 mg of lipids) of 
normotensive (NT) and hypertensive (HT) elderly subjects after consuming 
sunflower (SO) or virgin olive oil diets (VOO).
NT-SO HT-SO NT-VOO HT-VOO
Cholesteryl esters 41.1 ± 6.3a 38.8 ± 5.4ab 35.7± 5.6b 40.1 ± 4.1a
Free cholesterol 12.7 ± 1.7ab 12.0 ± 0.8a 13.2 ± 1.3b 13.5 ± 1.9b
Total cholesterol 53.8 ± 5.2a 50.8 ± 5.5b 48.9 ± 4.5b 53.6 ± 2.9a
Triacylglycerols 9.3 ± 1.7a 12.9 ± 1.9b 15.2 ± 2.6c 11.8 ± 2.7b
Diacylglycerols 2.9 ± 0.3a 2.4 ± 0.5a 4.8 ± 0.2b ND
Monoacylglycerols 1.8 ± 0.2a 1.8 ± 0.1a 2.6 ± 0.8a 2.2 ± 0.4a
Phospholipids 32.4 ± 5.5a 32.0 ± 5.1a 29.2 ± 7.5a 32.6 ± 5.3a
1  ± SD. n= 31.
2Mean values within a row sharing the same letter are not significantly 
different (p>0.01). 
3ND: Not detected.
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Table 5. Lipid classes composition of oxidized LDL (mg/100 mg of lipids) of normotensive 
(NT) and hypertensive (HT) elderly subjects after consuming sunflower (SO) or virgin olive 
oil diets (VOO).
NT-SO HT-SO NT-VOO HT-VOO
Cholesteryl esters 51.8 ± 3.8a 52.7 ± 3.8a 49.1 ± 5.2a 54.0 ± 4.3a
Free cholesterol 13.4 ± 2.2a 12.8 ± 1.4ab 13.5 ± 2.3a 12.0 ± 1.8b
Total cholesterol 65.2 ± 2.9a 65.5 ± 2.4a 62.6 ± 3.1b 66.0 ± 3.2a
Triacylglycerols 4.0 ± 0.5a 2.3 ± 0.6b 4.6 ± 0.8a 2.5 ± 0.2b
Diacylglycerols ND ND ND ND
Monoacylglycerols ND ND ND ND
Phospholipids 31.3 ± 2.9a 33.3 ± 3.4ab 34.2 ± 2.6b 33.4 ± 4.6ab
1  ± SD. n= 31.
2Mean values within a row sharing the same letter are not significantly 
different (p>0.01). 
3ND: Not detected.
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Figure 1. Systolic and diastolic pressures of normotensive (NT) and hypertensive (HT) 
elderly subjects after consuming sunflower (SO) or virgin olive oil diets (VOO). Mean 
values within a row sharing the same letter are not significantly different (p>0.01). 
Figure 2. Percentage of variation of cholesteryl esters (CE), free cholesterol (FC), total 
cholesterol (TC) and triacylglycerols (TG) in LDL due to oxidation in normotensive (NT) 
and hypertensive (HT) elderly subjects after consuming sunflower (SO) or virgin olive oil 
diets (VOO). Mean values within a row sharing the same letter are not significantly different 
(p>0.01). 
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